BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23336820)

  • 1. Perioperative complications in patients on low-molecular-weight heparin bridging therapy.
    Breen DT; Chavalertsakul N; Paul E; Gruen RL; Serpell J
    ANZ J Surg; 2016 Mar; 86(3):167-72. PubMed ID: 23336820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
    Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
    Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.
    Leijtens B; Kremers van de Hei K; Jansen J; Koëter S
    Arch Orthop Trauma Surg; 2014 Sep; 134(9):1335-41. PubMed ID: 24990654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
    Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
    Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.
    Spyropoulos AC; Frost FJ; Hurley JS; Roberts M
    Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
    Ong WL; Koh TL; Fletcher J; Gruen R; Royce P
    J Endourol; 2015 Nov; 29(11):1321-7. PubMed ID: 26154769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation bridging around device surgery: compliance with guidelines.
    Perrin MJ; Vezi BZ; Ha AC; Keren A; Nery PB; Birnie DH
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):1480-6. PubMed ID: 22978770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A; Brose S; Ploetze K; Matschke K
    Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.